Catalyst evidence graph changelog

https://catalystproject.ai/llms.txt

− - Entities: 117642− - Findings with a stated evidence strength (table `edges`): 1385− - Materialised paths: 397540, of which 1310 contain no inferred hop− - Papers indexed: 134284− - Sources cited by a finding (papers, trial registrations, reports): 836− - [curcumin](https://catalystproject.ai/compounds/curcumin): 139 findings, evidence from moderate to insufficient, 61 sources− - [melatonin](https://catalystproject.ai/compounds/melatonin): 77 findings, evidence from moderate to very limited, 50 sources− - [resveratrol](https://catalystproject.ai/compounds/resveratrol): 69 findings, evidence from strong to insufficient, 36 sources− - [magnesium(2+)](https://catalystproject.ai/compounds/magnesium-2): 60 findings, evidence from moderate to insufficient, 38 sources− - [caffeine](https://catalystproject.ai/compounds/caffeine): 59 findings, evidence from moderate to insufficient, 43 sources− - [L-glutamine](https://catalystproject.ai/compounds/l-glutamine): 47 findings, evidence from strong to insufficient, 28 sources− - [creatine](https://catalystproject.ai/compounds/creatine): 35 findings, evidence from moderate to insufficient, 22 sources− - [astaxanthin](https://catalystproject.ai/compounds/astaxanthin): 35 findings, evidence from moderate to insufficient, 16 sources− - [nitrate](https://catalystproject.ai/compounds/nitrate): 33 findings, evidence from moderate to very limited, 20 sources− - [calciol](https://catalystproject.ai/compounds/calciol): 24 findings, evidence from moderate to insufficient, 20 sources− - [lutein](https://catalystproject.ai/compounds/lutein): 19 findings, evidence from moderate to insufficient, 11 sources− - [Zn(2+)](https://catalystproject.ai/compounds/zn-2): 17 findings, evidence from strong to very limited, 7 sources− - [Ca(2+)](https://catalystproject.ai/compounds/ca-2): 16 findings, evidence from moderate to very limited, 11 sources− - [L-ascorbic acid](https://catalystproject.ai/compounds/l-ascorbic-acid): 15 findings, evidence from strong to insufficient, 12 sources− - [α-tocopherol](https://catalystproject.ai/compounds/alpha-tocopherol): 14 findings, evidence from moderate to very limited, 7 sources− - [selenium atom](https://catalystproject.ai/compounds/selenium-atom): 11 findings, evidence from moderate to limited, 4 sources− - [lycopene](https://catalystproject.ai/compounds/lycopene): 11 findings, evidence from moderate to insufficient, 9 sources− - [(R)-carnitine](https://catalystproject.ai/compounds/r-carnitine): 11 findings, evidence from moderate to limited, 6 sources− - [lipoic acid](https://catalystproject.ai/compounds/lipoic-acid): 11 findings, evidence from moderate to very limited, 5 sources− - [glucosamine](https://catalystproject.ai/compounds/glucosamine): 10 findings, evidence from moderate to very limited, 8 sources− - [all-cis-docosa-4,7,10,13,16,19-hexaenoic acid](https://catalystproject.ai/compounds/all-cis-docosa-4-7-10-13-16-19-hexaenoic-acid): 10 findings, evidence from moderate to insufficient, 9 sources− - [L-citrulline](https://catalystproject.ai/compounds/l-citrulline): 10 findings, evidence from moderate to insufficient, 8 sources− - [chromium(3+)](https://catalystproject.ai/compounds/chromium-3): 10 findings, evidence from moderate to very limited, 3 sources− - [aspartame](https://catalystproject.ai/compounds/aspartame): 9 findings, evidence from very limited to insufficient, 5 sources− - [taurine](https://catalystproject.ai/compounds/taurine): 8 findings, moderate evidence, 3 sources− - [N-acetyl-L-cysteine](https://catalystproject.ai/compounds/n-acetyl-l-cysteine): 7 findings, evidence from strong to limited, 5 sources− - [quercetin](https://catalystproject.ai/compounds/quercetin): 7 findings, evidence from moderate to very limited, 4 sources− - [chondroitin sulfate](https://catalystproject.ai/compounds/chondroitin-sulfate): 6 findings, evidence from very limited to insufficient, 6 sources− - [sodium hydrogencarbonate](https://catalystproject.ai/compounds/sodium-hydrogencarbonate): 6 findings, evidence from moderate to limited, 4 sources− - [L-cysteine](https://catalystproject.ai/compounds/l-cysteine): 6 findings, evidence from moderate to very limited, 2 sources− - [nicotinamide](https://catalystproject.ai/compounds/nicotinamide): 6 findings, evidence from strong to very limited, 3 sources− - [L-isoleucine](https://catalystproject.ai/compounds/l-isoleucine): 6 findings, evidence from very limited to insufficient, 5 sources− - [sodium(1+)](https://catalystproject.ai/compounds/sodium-1): 5 findings, evidence from moderate to very limited, 4 sources− - [Collagen](https://catalystproject.ai/compounds/collagen): 5 findings, evidence from moderate to very limited, 5 sources− - [thiamine](https://catalystproject.ai/compounds/thiamine): 5 findings, evidence from moderate to limited, 4 sources+ - Entities: 117692+ - Findings with a stated evidence strength (table `edges`): 2410+ - Materialised paths: 399997, of which 2317 contain no inferred hop+ - Papers indexed: 136965+ - Sources cited by a finding (papers, trial registrations, reports): 1503+ - [curcumin](https://catalystproject.ai/compounds/curcumin): 186 findings, evidence from moderate to insufficient, 71 sources+ - [magnesium(2+)](https://catalystproject.ai/compounds/magnesium-2): 168 findings, evidence from moderate to insufficient, 110 sources+ - [Zn(2+)](https://catalystproject.ai/compounds/zn-2): 108 findings, evidence from strong to very limited, 66 sources+ - [melatonin](https://catalystproject.ai/compounds/melatonin): 103 findings, evidence from strong to insufficient, 70 sources+ - [α-tocopherol](https://catalystproject.ai/compounds/alpha-tocopherol): 103 findings, evidence from moderate to very limited, 63 sources+ - [caffeine](https://catalystproject.ai/compounds/caffeine): 91 findings, evidence from moderate to insufficient, 65 sources+ - [Ca(2+)](https://catalystproject.ai/compounds/ca-2): 89 findings, evidence from moderate to insufficient, 60 sources+ - [resveratrol](https://catalystproject.ai/compounds/resveratrol): 79 findings, evidence from strong to insufficient, 44 sources+ - [selenium atom](https://catalystproject.ai/compounds/selenium-atom): 69 findings, evidence from moderate to insufficient, 42 sources+ - [calciol](https://catalystproject.ai/compounds/calciol): 61 findings, evidence from moderate to insufficient, 48 sources+ - [chromium(3+)](https://catalystproject.ai/compounds/chromium-3): 58 findings, evidence from limited to very limited, 25 sources+ - [all-trans-retinol](https://catalystproject.ai/compounds/all-trans-retinol): 52 findings, evidence from strong to insufficient, 46 sources+ - [L-glutamine](https://catalystproject.ai/compounds/l-glutamine): 50 findings, evidence from strong to insufficient, 30 sources+ - [L-ascorbic acid](https://catalystproject.ai/compounds/l-ascorbic-acid): 41 findings, evidence from strong to insufficient, 36 sources+ - [astaxanthin](https://catalystproject.ai/compounds/astaxanthin): 39 findings, evidence from moderate to insufficient, 19 sources+ - [creatine](https://catalystproject.ai/compounds/creatine): 36 findings, evidence from moderate to insufficient, 23 sources+ - [nitrate](https://catalystproject.ai/compounds/nitrate): 33 findings, evidence from moderate to very limited, 20 sources+ - [K(+)](https://catalystproject.ai/compounds/k): 29 findings, evidence from moderate to very limited, 20 sources+ - [folic acid](https://catalystproject.ai/compounds/folic-acid): 22 findings, evidence from moderate to very limited, 20 sources+ - [(R)-carnitine](https://catalystproject.ai/compounds/r-carnitine): 19 findings, evidence from moderate to very limited, 11 sources+ - [lutein](https://catalystproject.ai/compounds/lutein): 19 findings, evidence from moderate to insufficient, 11 sources+ - [thiamine](https://catalystproject.ai/compounds/thiamine): 18 findings, evidence from moderate to very limited, 16 sources+ - [lipoic acid](https://catalystproject.ai/compounds/lipoic-acid): 15 findings, evidence from moderate to very limited, 8 sources+ - [L-citrulline](https://catalystproject.ai/compounds/l-citrulline): 15 findings, evidence from moderate to insufficient, 12 sources+ - [pyridoxine](https://catalystproject.ai/compounds/pyridoxine): 15 findings, evidence from very limited to insufficient, 15 sources+ - [lycopene](https://catalystproject.ai/compounds/lycopene): 14 findings, evidence from moderate to insufficient, 11 sources+ - [iron(2+)](https://catalystproject.ai/compounds/iron-2): 14 findings, evidence from moderate to very limited, 12 sources+ - [taurine](https://catalystproject.ai/compounds/taurine): 13 findings, evidence from moderate to insufficient, 5 sources+ - [glucosamine](https://catalystproject.ai/compounds/glucosamine): 13 findings, evidence from moderate to very limited, 10 sources+ - [riboflavin](https://catalystproject.ai/compounds/riboflavin): 11 findings, evidence from moderate to insufficient, 10 sources+ - [all-cis-docosa-4,7,10,13,16,19-hexaenoic acid](https://catalystproject.ai/compounds/all-cis-docosa-4-7-10-13-16-19-hexaenoic-acid): 11 findings, evidence from moderate to insufficient, 10 sources+ - [quercetin](https://catalystproject.ai/compounds/quercetin): 11 findings, evidence from moderate to insufficient, 7 sources+ - [sodium hydrogencarbonate](https://catalystproject.ai/compounds/sodium-hydrogencarbonate): 10 findings, evidence from moderate to limited, 6 sources+ - [choline](https://catalystproject.ai/compounds/choline): 9 findings, evidence from moderate to very limited, 8 sources+ - [Cu(2+)](https://catalystproject.ai/compounds/cu-2): 9 findings, evidence from moderate to limited, 6 sources

Showing the first 40 of each.

https://catalystproject.ai/llms.txt

− - Entities: 117466− - Materialised paths: 391315, of which 1227 contain no inferred hop− - Papers indexed: 133512+ - Entities: 117642+ - Materialised paths: 397540, of which 1310 contain no inferred hop+ - Papers indexed: 134284

https://catalystproject.ai/llms.txt

− - Entities: 117119− - Findings with a stated evidence strength (table `edges`): 1041− - Materialised paths: 390605, of which 973 contain no inferred hop− - Papers indexed: 89649− - Sources cited by a finding (papers, trial registrations, reports): 633− - [melatonin](https://catalystproject.ai/compounds/melatonin): 75 findings, evidence from moderate to very limited, 48 sources− - [resveratrol](https://catalystproject.ai/compounds/resveratrol): 66 findings, evidence from strong to insufficient, 33 sources− - [coenzyme Q10](https://catalystproject.ai/compounds/coenzyme-q10): 65 findings, evidence from moderate to very limited, 32 sources− - [magnesium(2+)](https://catalystproject.ai/compounds/magnesium-2): 56 findings, evidence from moderate to insufficient, 34 sources− - [berberine](https://catalystproject.ai/compounds/berberine): 51 findings, evidence from moderate to insufficient, 28 sources− - [L-glutamine](https://catalystproject.ai/compounds/l-glutamine): 43 findings, evidence from strong to insufficient, 27 sources− - [astaxanthin](https://catalystproject.ai/compounds/astaxanthin): 32 findings, evidence from moderate to insufficient, 14 sources− - [creatine](https://catalystproject.ai/compounds/creatine): 32 findings, evidence from moderate to insufficient, 20 sources− - [L-arginine](https://catalystproject.ai/compounds/l-arginine): 31 findings, evidence from moderate to very limited, 18 sources− - [calciol](https://catalystproject.ai/compounds/calciol): 22 findings, evidence from moderate to insufficient, 18 sources− - [(-)-epigallocatechin 3-gallate](https://catalystproject.ai/compounds/epigallocatechin-3-gallate): 19 findings, evidence from very limited to insufficient, 13 sources− - [lutein](https://catalystproject.ai/compounds/lutein): 18 findings, evidence from moderate to insufficient, 10 sources− - [methylene blue](https://catalystproject.ai/compounds/methylene-blue): 11 findings, evidence from strong to insufficient, 8 sources− - [empagliflozin](https://catalystproject.ai/compounds/empagliflozin): 10 findings, evidence from moderate to very limited, 4 sources− - [lipoic acid](https://catalystproject.ai/compounds/lipoic-acid): 9 findings, evidence from moderate to very limited, 3 sources− - [all-cis-docosa-4,7,10,13,16,19-hexaenoic acid](https://catalystproject.ai/compounds/all-cis-docosa-4-7-10-13-16-19-hexaenoic-acid): 9 findings, evidence from moderate to insufficient, 8 sources− - [L-citrulline](https://catalystproject.ai/compounds/l-citrulline): 9 findings, evidence from moderate to insufficient, 7 sources− - [tirzepatide](https://catalystproject.ai/compounds/tirzepatide): 7 findings, moderate evidence, 3 sources− - [spironolactone](https://catalystproject.ai/compounds/spironolactone): 7 findings, evidence from moderate to very limited, 3 sources− - [(R)-carnitine](https://catalystproject.ai/compounds/r-carnitine): 7 findings, moderate evidence, 3 sources− - [aspartame](https://catalystproject.ai/compounds/aspartame): 6 findings, evidence from very limited to insufficient, 4 sources− - [glucosamine](https://catalystproject.ai/compounds/glucosamine): 6 findings, evidence from moderate to very limited, 5 sources− - [pravastatin](https://catalystproject.ai/compounds/pravastatin): 6 findings, evidence from moderate to very limited, 3 sources− - [sucralose](https://catalystproject.ai/compounds/sucralose): 5 findings, evidence from limited to very limited, 4 sources− - [finasteride](https://catalystproject.ai/compounds/finasteride): 4 findings, moderate evidence, 2 sources− - [cannabidiol](https://catalystproject.ai/compounds/cannabidiol): 4 findings, moderate evidence, 4 sources− - [L-leucine](https://catalystproject.ai/compounds/l-leucine): 3 findings, evidence from moderate to insufficient, 3 sources− - [acrylamide](https://catalystproject.ai/compounds/acrylamide): 3 findings, evidence from moderate to very limited, 3 sources− - [bisphenol A](https://catalystproject.ai/compounds/bisphenol-a): 3 findings, moderate evidence, 3 sources− - [vitamin D2](https://catalystproject.ai/compounds/vitamin-d2): 3 findings, evidence from moderate to very limited, 2 sources− - [L-isoleucine](https://catalystproject.ai/compounds/l-isoleucine): 3 findings, evidence from very limited to insufficient, 2 sources− - [sertraline](https://catalystproject.ai/compounds/sertraline): 3 findings, evidence from moderate to very limited, 2 sources− - [titanium dioxide](https://catalystproject.ai/compounds/titanium-dioxide): 3 findings, limited evidence, 1 source− - [quetiapine](https://catalystproject.ai/compounds/quetiapine): 3 findings, moderate evidence, 1 source− - [lycopene](https://catalystproject.ai/compounds/lycopene): 3 findings, evidence from moderate to very limited, 3 sources+ - Entities: 117466+ - Findings with a stated evidence strength (table `edges`): 1385+ - Materialised paths: 391315, of which 1227 contain no inferred hop+ - Papers indexed: 133512+ - Sources cited by a finding (papers, trial registrations, reports): 836+ - [melatonin](https://catalystproject.ai/compounds/melatonin): 77 findings, evidence from moderate to very limited, 50 sources+ - [resveratrol](https://catalystproject.ai/compounds/resveratrol): 69 findings, evidence from strong to insufficient, 36 sources+ - [coenzyme Q10](https://catalystproject.ai/compounds/coenzyme-q10): 67 findings, evidence from moderate to insufficient, 34 sources+ - [magnesium(2+)](https://catalystproject.ai/compounds/magnesium-2): 60 findings, evidence from moderate to insufficient, 38 sources+ - [berberine](https://catalystproject.ai/compounds/berberine): 56 findings, evidence from moderate to insufficient, 30 sources+ - [L-glutamine](https://catalystproject.ai/compounds/l-glutamine): 47 findings, evidence from strong to insufficient, 28 sources+ - [creatine](https://catalystproject.ai/compounds/creatine): 35 findings, evidence from moderate to insufficient, 22 sources+ - [astaxanthin](https://catalystproject.ai/compounds/astaxanthin): 35 findings, evidence from moderate to insufficient, 16 sources+ - [L-arginine](https://catalystproject.ai/compounds/l-arginine): 33 findings, evidence from moderate to insufficient, 20 sources+ - [calciol](https://catalystproject.ai/compounds/calciol): 24 findings, evidence from moderate to insufficient, 20 sources+ - [(-)-epigallocatechin 3-gallate](https://catalystproject.ai/compounds/epigallocatechin-3-gallate): 20 findings, evidence from limited to insufficient, 14 sources+ - [lutein](https://catalystproject.ai/compounds/lutein): 19 findings, evidence from moderate to insufficient, 11 sources+ - [empagliflozin](https://catalystproject.ai/compounds/empagliflozin): 19 findings, evidence from moderate to very limited, 7 sources+ - [Zn(2+)](https://catalystproject.ai/compounds/zn-2): 17 findings, evidence from strong to very limited, 7 sources+ - [pravastatin](https://catalystproject.ai/compounds/pravastatin): 16 findings, evidence from moderate to very limited, 5 sources+ - [Ca(2+)](https://catalystproject.ai/compounds/ca-2): 16 findings, evidence from moderate to very limited, 11 sources+ - [L-ascorbic acid](https://catalystproject.ai/compounds/l-ascorbic-acid): 15 findings, evidence from strong to insufficient, 12 sources+ - [crocin-1](https://catalystproject.ai/compounds/crocin-1): 14 findings, evidence from moderate to very limited, 5 sources+ - [α-tocopherol](https://catalystproject.ai/compounds/alpha-tocopherol): 14 findings, evidence from moderate to very limited, 7 sources+ - [methylene blue](https://catalystproject.ai/compounds/methylene-blue): 13 findings, evidence from strong to insufficient, 9 sources+ - [tirzepatide](https://catalystproject.ai/compounds/tirzepatide): 12 findings, moderate evidence, 4 sources+ - [selenium atom](https://catalystproject.ai/compounds/selenium-atom): 11 findings, evidence from moderate to limited, 4 sources+ - [lycopene](https://catalystproject.ai/compounds/lycopene): 11 findings, evidence from moderate to insufficient, 9 sources+ - [(R)-carnitine](https://catalystproject.ai/compounds/r-carnitine): 11 findings, evidence from moderate to limited, 6 sources+ - [lipoic acid](https://catalystproject.ai/compounds/lipoic-acid): 11 findings, evidence from moderate to very limited, 5 sources+ - [glucosamine](https://catalystproject.ai/compounds/glucosamine): 10 findings, evidence from moderate to very limited, 8 sources+ - [all-cis-docosa-4,7,10,13,16,19-hexaenoic acid](https://catalystproject.ai/compounds/all-cis-docosa-4-7-10-13-16-19-hexaenoic-acid): 10 findings, evidence from moderate to insufficient, 9 sources+ - [L-citrulline](https://catalystproject.ai/compounds/l-citrulline): 10 findings, evidence from moderate to insufficient, 8 sources+ - [chromium(3+)](https://catalystproject.ai/compounds/chromium-3): 10 findings, evidence from moderate to very limited, 3 sources+ - [aspartame](https://catalystproject.ai/compounds/aspartame): 9 findings, evidence from very limited to insufficient, 5 sources+ - [NMN zwitterion](https://catalystproject.ai/compounds/nmn-zwitterion): 9 findings, evidence from moderate to very limited, 3 sources+ - [taurine](https://catalystproject.ai/compounds/taurine): 8 findings, moderate evidence, 3 sources+ - [spironolactone](https://catalystproject.ai/compounds/spironolactone): 8 findings, evidence from moderate to very limited, 4 sources+ - [N-acetyl-L-cysteine](https://catalystproject.ai/compounds/n-acetyl-l-cysteine): 7 findings, evidence from strong to limited, 5 sources+ - [quercetin](https://catalystproject.ai/compounds/quercetin): 7 findings, evidence from moderate to very limited, 4 sources

Showing the first 40 of each.

• + evidence-card
• + guide

• + answer_with_evidence

• + find_evidence